Elastomeric infusion pumps market

Elastomeric Infusion Pumps Market, by Product Type (Variable Rate Elastomeric Pumps, Continuous Rate Elastomeric Pumps), by Treatment (Pain Management, Antibiotic/Antiviral, Chemotherapy, Others), by End User (Ambulatory Surgical Centers, Clinics, Home Care Settings, Hospitals, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031

Request Free Sample

Mar 2024
CMI3129
220 Pages
Excel & Pdf
Medical Devices

Summary

Elastomeric infusion pumps, also known as disposable balloon pumps, are used to administer intravenous (IV) drugs such as local anesthetics, antibiotics, and anti-neoplastic. These non-electronic, non-gravity driven devices are used in single infusions. Elastomeric infusion pumps contain a stretchable balloon reservoir that is filled with a drug and pressure from the elastic walls drives fluid delivery with relatively consistent pressure until it reaches near the end of the infusion.

Global elastomeric infusion pumps market is estimated to be valued at USD 1,255.4 Mn in 2024 and is expected to exhibit a CAGR of 9.2% during the forecast period (2024-2031).

Figure 1. Global Elastomeric Infusion Pumps Market Value (US$ Mn), by Region, 2024

Post-operative pain in surgeries such as total knee replacement and total hip replacement is usually treated by infusion of analgesics through disposable infusion pumps. Therefore, increasing number of orthopedic procedures and surgeries is expected to boost growth of the global elastomeric infusion pumps market over the forecast period.

For instance, according to a 2018 report by American Academy of Orthopedic Surgeons, over 1 million patients and over 1.4 million hip and knee arthroplasty procedures were entered into the American Joint Replacement Registry.

Elastomeric Infusion Pumps Market Report Coverage

Report Coverage	Details
Base Year:	2023	Market Size in 2024:	US$ 1,255.4 Mn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	9.2%	2031 Value Projection:	US$ 2,327.3 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Product Type: Variable Rate Elastomeric Pumps, Continuous Rate Elastomeric Pumps By Treatment: Pain management, Antibiotic/Antiviral, Chemotherapy, Others By End User: Ambulatory Surgical Centers, Clinics, Home Care Settings, Hospitals, Others
Companies covered:	B. Braun Melsungen AG, Fresenius Kabi, Leventon, S.A.U, Ambu A/S, Baxter International Inc., Halyard Health, and Nipro Corporation
Growth Drivers:	Increasing number of orthopedic procedures and surgeries Increasing incidence of chronic blood diseases such as blood cancer
Restraints & Challenges:	High cost of elastomeric infusion pump products

Figure 2. Global Elastomeric Infusion Pumps Market Share, by treatment, 2024

The increasing incidence of chronic blood diseases such as blood cancer is expected to drive growth of the global elastomeric infusion pumps market over the forecast period.

The increasing incidence of chronic blood diseases such as blood cancers which include leukemia, lymphoma, and myeloma or blood disorders such as anemia or bleeding disorders such as blood clots and hemophilia is expected to drive growth of the global elastomeric infusion pumps market over the forecast period.

For instance, According to the Centers for Disease Control and Prevention (CDC) in 2019, the Sickle Cell Disease (SCD) affects around 100,000 Americans each year. Moreover, according to Leukemia & Lymphoma Society, it was estimated that around 172,910 people in the U.S. were expected to be diagnosed with the leukemia, lymphoma or myeloma in 2017.

Global Elastomeric Infusion Pumps Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.

COVID-19 has affected the economy in three main ways: by directly affecting production and demand of drugs and vaccines, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, UAE, Egypt, and others, faced problems with regard to the transportation of drugs and vaccines from one place to another. Elastomeric infusion pumps market faced negative impact due COVID-19 as there was lack of transportation facility of raw material used to manufacture infusion pumps.

Recent Developments

On January 4, 2024, the East and North Hertfordshire NHS Trust, an organizational entity within the National Health Services of England and Wales, announced the launch of a new elastomeric pump pathway for hospital at home patients in East and North Hertfordshire. For patients on antibiotics, the elastomeric device enables nurses to deliver medications with just one visit each day, reducing the number of nursing visits by half.

Global Elastomeric Infusion Pumps Market: Restraint

The costs of elastomeric infusion pumps keep fluctuating depending on the type of the pumps. For instance, the cost of pumps administering antibiotics is significantly low, whereas the cost of pumps administering pain management drugs is relatively high. Such scenario is expected to hinder growth of the global elastomeric infusion pumps market over the forecast period.

Moreover, stringent regulations regarding the use of plastics in elastomeric infusion pumps is also expected to hamper the market growth. For instance, the European Commission and the U.S. Food and Drug Administration (FDA) published safety assessments of medical devices containing Di (2-ethylhexyl) phthalate (DEHP) and plasticized polyvinylchloride (PVC) in parts of elastomeric infusion pumps. Therefore, manufacturers need to focus on proper safety labeling of products to avoid severe side effects, especially in neonatal patient population.

Key Players

Major players operating in the global elastomeric infusion pumps market include B. Braun Melsungen AG, Fresenius Kabi, Leventon, S.A.U, Ambu A/S, Baxter International Inc., Halyard Health, and Nipro Corporation.

Table of Content

Table of Contents

Segmentation

Detailed Segmentation:

- Frequently Asked Questions -

What is the current market size and compound annual growth rate (CAGR) of the global elastomeric infusion pumps market during the forecast period (2024-2031)?

Global elastomeric infusion pumps market size is estimated to be valued at USD 1,255.4 MN in 2024 and is expected to exhibit a CAGR of 9.2% between 2024 and 2031.

What are the major factors driving the market growth?

Factors such as increasing number of orthopedic procedures and surgeries and increasing incidence of chronic blood diseases such as blood cancer are expected to drive the market growth.

Which segment based on product type, accounted for highest demand segment, in the market?

Among product type, continuous rate elastomeric pumps segment accounted for a major market share and is in high demand.

What are the key factors hampering growth of the market?

The major factors hampering growth of the market include high cost of elastomeric infusion pump products.

Which are the major players operating in the market?

Major players operating in the market include B. Braun Melsungen AG, Fresenius Kabi, Leventon, S.A.U, Ambu A/S, Baxter International Inc., Halyard Health, and Nipro Corporation.